Neuropeptide Y-induced coronary microvascular dysfunction: A significant contributor to the adverse outcomes in stress cardiomyopathy?

International Journal of Cardiology

Volumn 147, Issue 2, 2011, Pages 284-

  Yalta, Kenan ^a   Sivri, Nasir ^a   Yalta, Tulin ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Coronary microvascular dysfunction; Neuropeptide Y; Stress cardiomyopathy

Indexed keywords

NEUROPEPTIDE Y;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; CORONARY MICROVASCULAR DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HUMAN; LETTER; MICROVASCULARIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TAKOTSUBO CARDIOMYOPATHY;

EID: 79951945749     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.095     Document Type: Article

References (6)

1. Szardien S, Möllmann H, VoßS, Troidl C, Rolf A, Liebetrau C, Rixe J, Elsässer A, Hamm CW, Nef HM. Elevated serum levels of neuropeptide Y in stress cardiomyopathy. Int J Cardiol 2011;147:155-7.
2. Biteker M, Duran NE, Gökdeniz T, Gündüz S, Güler A, Kaya H, Yildiz M, Ozkan M. Takotsubo cardiomyopathy mimicking acute high lateral myocardial infarction. Anadolu Kardiyol Derg 2010;10(1):E2-3.
3. Bonello L, Com O, Ait-Moktar O, et al. Ventricular arrhythmias during Tako-tsubo syndrome. Int J Cardiol 2008;128(2):e50-3.
4. Muxel S, Fineschi M, Hauser ER, Gori T. Coronary slow flow or syndrome Y: Dysfunction at rest, preserved reactivity of the peripheral endothelium. Int J Cardiol 2011;147:151-3.
5. Fineschi M, Gori T. Coronary slow flow: description of a new "cardiac Y" syndrome. Int J Cardiol 2009;137(3):308-10.
6. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.